Literature DB >> 17298956

Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Nikolaos Scarmeas1.   

Abstract

Because of the aging of the population, dementia has become a major public health problem. There has been growing evidence for a possible association between lipids and dementia. A large body of literature has demonstrated multiple hypothesized biologic links between lipids and neurodegenerative or other biologic pathways connected to dementing processes. However, the epidemiologic associations have been conflicting: dyslipidemia at middle age, but not in later life, seems to be associated with higher dementia risk in some but not all studies. Results from the Honolulu-Asia Aging Study reported by Saczynski et al. (Am J Epidemiol 2007;165:985-92) suggest that lipoprotein constituents, such as apolipoprotein A-I, a major component of the high density lipoprotein, may be more informative in enlightening the association between lipids and dementia. In this commentary, the epidemiology and biology of apolipoprotein A-I in relation to dementia is reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298956      PMCID: PMC3627057          DOI: 10.1093/aje/kwm033

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  71 in total

1.  Apolipoproteins in human cerebrospinal fluid.

Authors:  P S Roheim; M Carey; T Forte; G L Vega
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

Authors:  R E Pitas; J K Boyles; S H Lee; D Hui; K H Weisgraber
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

3.  Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.

Authors:  Kulandaivelu S Vetrivel; Haipeng Cheng; William Lin; Takashi Sakurai; Tong Li; Nobuyuki Nukina; Philip C Wong; Huaxi Xu; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

4.  Dementia: the leading predictor of death in a defined elderly population: the Cache County Study.

Authors:  J T Tschanz; C Corcoran; I Skoog; A S Khachaturian; J Herrick; K M Hayden; K A Welsh-Bohmer; T Calvert; M C Norton; P Zandi; J C S Breitner
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

5.  Relation of plasma lipids to Alzheimer disease and vascular dementia.

Authors:  Christiane Reitz; Ming-Xin Tang; Jose Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2004-05

Review 6.  Cholesterol modulates amyloid beta-peptide's membrane interactions.

Authors:  Gunter P Eckert; Christopher Kirsch; Steffen Leutz; W Gibson Wood; Walter E Müller
Journal:  Pharmacopsychiatry       Date:  2003-09       Impact factor: 5.788

7.  Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.

Authors:  M A Pappolla; T K Bryant-Thomas; D Herbert; J Pacheco; M Fabra Garcia; M Manjon; X Girones; T L Henry; E Matsubara; D Zambon; B Wolozin; M Sano; F F Cruz-Sanchez; L J Thal; S S Petanceska; L M Refolo
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

8.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke.

Authors:  Roberto Paternò; Antonio Ruocco; Alfredo Postiglione; Alphonse Hubsch; Irmgard Andresen; Markus G Lang
Journal:  Cerebrovasc Dis       Date:  2003-12-29       Impact factor: 2.762

View more
  4 in total

1.  Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-30       Impact factor: 8.311

2.  Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.

Authors:  Wookju Jang; Nam Ho Jeoung; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2011-04-21       Impact factor: 5.034

Review 3.  Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Sarah Förster; Jessica L Harris; Rukhsana Sultana; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

4.  Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

Authors:  Terry L Lewis; Dongfeng Cao; Hailin Lu; Robert A Mans; Yan Ru Su; Lisa Jungbauer; MacRae F Linton; Sergio Fazio; Mary Jo LaDu; Ling Li
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.